Correction to: BRAF Inhibitor Resistance in Meslanoma: Mechanisms and Alternative Therapeutic Strategies

Conflict of Interest

This work was supported by Shanghai Science and Technology Development Funds (19411951700), the Lingang Laboratory (Grant No. LG-QS-202205-11), and the national natural science foundation of China (81802636).

JZ wrote and edited this manuscript and created tables and figure. JZ, ZZ, WS, WY, CW, WL, XL, and YC reviewed and revised the manuscript. WS and YC provided direction and guidance throughout the preparation of the manuscript. All authors read and approved the final manuscript.

The original article has been corrected.

留言 (0)

沒有登入
gif